Chan, Shingpan <br/><br/>
2,4-Diarylamino-pyrimidines as kinase inhibitors co-targeting IGF1R and EGFR(L⁸⁵⁸R/T⁷⁹⁰M).  [electronic resource] 

 -  Bioorganic & medicinal chemistry letters  Oct 2015 
 - 4277-81 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1464-3405 
<br/><br/><label>Standard No.: </label>10.1016/j.bmcl.2015.07.089  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--chemical synthesis<br/>Cell Line, Tumor<br/>Cell Proliferation--drug effects<br/>Dose-Response Relationship, Drug<br/>Drug Screening Assays, Antitumor<br/>ErbB Receptors--antagonists & inhibitors<br/>Humans<br/>Models, Molecular<br/>Molecular Structure<br/>Protein Kinase Inhibitors--chemical synthesis<br/>Receptor, IGF Type 1<br/>Receptors, Somatomedin--antagonists & inhibitors<br/>Structure-Activity Relationship